A Phase I study of pevonedistat plus capecitabine plus oxaliplatin in patients with advanced gastric cancer refractory to platinum (NCCH-1811)

Based on synergistic anti-tumor effects between blockades of NEDD8 activating enzyme and a platinum in preclinical studies, this Phase I study is designed to investigate the safety and tolerability of pevonedistat in combination with capecitabine plus oxaliplatin as third-line or later treatment in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Future Sci OA
Main Authors: Shoji, Hirokazu, Takahari, Daisuke, Hara, Hiroki, Nagashima, Kengo, Adachi, Jun, Boku, Narikazu
Formato: Artigo
Idioma:Inglês
Publicado em: Future Science Ltd 2021
Assuntos:
Clinical Trial Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8256327/
https://ncbi.nlm.nih.gov/pubmed/34258028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2144/fsoa-2021-0023
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados